CCL2 and breast cancer: This overexpression increases monocyte recruitment and promotes the migration of HER2 + breast cancer cells through the CCL2/CCR2/MAPK pathway, underscoring the significant impact of TAM-derived MMP-11 on the progression and metastatic potential of breast cancer (Kang et al. 2022).